214 related articles for article (PubMed ID: 23195777)
1. Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging.
Lin YC; Wang JJ; Hong JH; Lin YP; Lee CC; Wai YY; Ng SH; Wu YM; Wang CC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1367-74. PubMed ID: 23195777
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging.
Robinson SP; Howe FA; Griffiths JR
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):855-9. PubMed ID: 7591894
[TBL] [Abstract][Full Text] [Related]
3. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
de Lussanet QG; Backes WH; Griffioen AW; Padhani AR; Baeten CI; van Baardwijk A; Lambin P; Beets GL; van Engelshoven JM; Beets-Tan RG
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1309-15. PubMed ID: 16125874
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
[TBL] [Abstract][Full Text] [Related]
6. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study.
Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM
J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027
[TBL] [Abstract][Full Text] [Related]
7. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
[TBL] [Abstract][Full Text] [Related]
8. Elimination of visually evoked BOLD responses during carbogen inhalation: implications for calibrated MRI.
Gauthier CJ; Madjar C; Tancredi FB; Stefanovic B; Hoge RD
Neuroimage; 2011 Jan; 54(2):1001-11. PubMed ID: 20887792
[TBL] [Abstract][Full Text] [Related]
9. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
11. Blood oxygen level-dependent MRI for evaluation of early response of liver tumors to chemoembolization: an animal study.
Choi JW; Kim H; Kim HC; Lee Y; Kwon J; Yoo RE; Cho HR; Choi SH; Chung JW
Anticancer Res; 2013 May; 33(5):1887-92. PubMed ID: 23645735
[TBL] [Abstract][Full Text] [Related]
12. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
13. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
15. Early effects of combretastatin A4 phosphate assessed by anatomic and carbogen-based functional magnetic resonance imaging on rat bladder tumors implanted in nude mice.
Thomas CD; Walczak C; Kaffy J; Pontikis R; Jouanneau J; Volk A
Neoplasia; 2006 Jul; 8(7):587-95. PubMed ID: 16867221
[TBL] [Abstract][Full Text] [Related]
16. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
[TBL] [Abstract][Full Text] [Related]
17. Towards noninvasive human tumor physiologic measurements.
Okunieff P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):961-2. PubMed ID: 7591910
[No Abstract] [Full Text] [Related]
18. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
Nöth U; Rodrigues LM; Robinson SP; Jork A; Zimmermann U; Newell B; Griffiths JR
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):909-19. PubMed ID: 15465209
[TBL] [Abstract][Full Text] [Related]
19. Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study.
Jiang L; Weatherall PT; McColl RW; Tripathy D; Mason RP
J Magn Reson Imaging; 2013 May; 37(5):1083-92. PubMed ID: 23124705
[TBL] [Abstract][Full Text] [Related]
20. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
